MR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
27.673
Exchange
XNAS - Nasdaq
-5.289
Last period CFO / Debt ratio ,USD
60%
CFO / Debt ratio has increased in 5 years
What is CFO / Debt ratio ?
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
See also Moderna
Company Analysis
MRNA valuation, rating, competitors, insights and company profile
Eyestock Rating
MRNA financial analysis by Eyestock methodology
Valuation
MRNA valuation using historical relative method
Statements
MRNA Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MRNA dividend yield and annual dividend
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
Moderna`s CFO / Debt ratio for the last twelve months ended 2024-06-30 is -5.289
